【レポートの概要（一部）】
1. Analyst View
2. Research Methodology
3. Global Protein Therapeutics Market
3.1 Protein Therapeutics Market vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2020
3.2.1 Market Segmentation
3.2.2 Market Dynamics
3.2.2.1 Drivers
3.2.2.1.1 Increasing Healthcare Expenditure in the Emerging Markets
3.2.2.1.2 Government Initiatives to Improve the Healthcare Services
3.2.2.1.3 Rising Prevalence of Chronic Diseases
3.2.2.1.4 Growing Geriatric Population
3.2.2.2 Challenges
3.2.2.2.1 High Cost of Production and Treatment
3.2.2.2.2 Competition from Biosimilars
3.2.2.2.3 Patent Expiry of Blockbuster Drugs
3.2.2.3 Opportunities
3.2.2.3.1 Potential for Bispecific Monoclonal Antibodies
3.2.2.3.2 Unmet Medical Needs in the Developing Countries
4. Industry Performance
4.1 Monoclonal Antibodies (mAbs)
4.1.1 Scientific Insight
4.1.2 Current and Future Market Analysis to 2020
4.1.3 By Application
4.1.4 Key Geographical Markets
4.1.5 Key Players and Drugs
4.1.6 Recent Developments
4.2 Erythropoietin (EPO)
4.2.1 Scientific Insight
4.2.2 Current and Future Market Analysis to 2020
4.2.3 By Application
4.2.4 Key Geographical Markets
4.2.5 Key Players and Drugs
4.2.6 Recent Developments
4.3 Insulin
4.3.1 Scientific Insight
4.3.2 Current and Future Market Analysis to 2020
4.3.3 By Application
4.3.4 Key Geographical Markets
4.3.5 Key Players and Drugs
4.3.6 Recent Developments
4.4 Interferon (IFN)
4.4.1 Scientific Insight
4.4.2 Current and Future Market Analysis to 2020
4.4.3 By Application
4.4.4 Key Geographical Markets
4.4.5 Key Players and Drugs
4.4.6 Recent Developments
4.5 Human Growth Hormone (HGH)
4.5.1 Scientific Insight
4.5.2 Current and Future Market Analysis to 2020
4.5.3 Key Geographical Markets
4.5.4 Key Players and Drugs
4.5.5 Recent Developments
4.6 Blood Clotting Factor
4.6.1 Scientific Insight
4.6.2 Current and Future Market Analysis to 2020
4.6.3 By Factor Type
4.6.4 Key Geographical Markets
4.6.5 Key Players and Drugs
4.6.6 Recent Developments
4.7 Follicle Stimulating Hormone (FSH)
4.7.1 Scientific Insight
4.7.2 Current and Future Market Analysis to 2020
4.7.3 Key Players and Drugs
4.7.4 Recent Developments
4.8 Granulocyte Colony Stimulating Factor (G-CSF)
4.8.1 Scientific Insight
4.8.2 Current and Future Market Analysis to 2020
4.8.3 Key Geographical Markets
4.8.4 Key Players and Drugs
4.8.5 Recent Developments
5. Advanced Phase Drugs Analysis
6. Emerging Market Trends
6.1 Gaining Momentum: Strategic Activities among Players to Develop Novel Treatments
6.2 Effective Delivery Methods: Improving the Reach of Therapies
6.3 Players Investing Heavily in Multiple Sclerosis and Cancer Therapeutics
6.4 Increasing Focus on Development of Biobetters
7. Porters Five Forces Analysis
8. Key Players
8.1 Johnson & Johnson
8.2 Biogen Idec Inc.
8.3 Eli Lilly & Company
8.4 Sanofi-Aventis
8.5 Merck Serono S.A.
8.6 Roche Group
8.7 Amgen Inc.
8.8 Pfizer
8.9 Abbott Laboratories
8.10 Novo Nordisk
List of Figures:
Figure 3-1: Global – Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2014
Figure 3-2: Global – Protein Therapeutics Market (Billion US$), 2013-2020
Figure 3-3: Global – Protein Therapeutics Market by Segment (%), 2014
Figure 3-4: Global – Forecast for Protein Therapeutics Market by Segment (%), 2020
Figure 4-1: Global – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-2: Global – Monoclonal Antibodies Market by Application (%), 2014
Figure 4-3: Global – Monoclonal Antibodies Application in Cancer Treatment (Billion US$), 2013-2020
Figure 4-4: Global – Monoclonal Antibodies Application in Rheumatoid Arthritis Treatment (Billion US$), 2013-2020
Figure 4-5: Global – Monoclonal Antibodies Application in Other Chronic Diseases Treatment (Billion US$), 2013-2020
Figure 4-6: US – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-7: Europe – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-8: Japan – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-9: Global – Monoclonal Antibody Market by Key Players (%) (2014)
Figure 4-10: Global – Erythropoietin Market (Billion US$), 2012-2018
Figure 4-11: Global – Erythropoietin Market by Segment (%) (2014)
Figure 4-12: Global – Number of Patients on Dialysis (Million), 2014 & 2020
Figure 4-13: Global – Breakup of Patients on Dialysis by Region (%), 2014
Figure 4-14: Global – Number of New Cancer Cases (Million), 2012 & 2020
Figure 4-15: Global – Breakup of New Cancer Cases by Region (%), 2020
Figure 4-16: US – Erythropoietin Market (Billion US$), 2013-2020
Figure 4-17: Europe – Erythropoietin Market (Billion US$), 2013-2020
Figure 4-18: Global – Erythropoietin Market by Key Player (%), (2014)
Figure 4-19: Global – Insulin Market (Billion US$), 2013-2020
Figure 4-20: Global – Number of Diabetic Patients (Million), 2013 & 2035
Figure 4-21: US – Insulin Market (Billion US$), 2013-2020
Figure 4-22: Europe – Insulin Market (Billion US$), 2013-2020
Figure 4-23: Asia – Insulin Market (Billion US$), 2013-2020
Figure 4-24: Global – Insulin Market by Key Players (%) (2014)
Figure 4-25: Global – Insulin Market by Products (%)(2014)
Figure 4-26: Global – Interferon Market (Billion US$), 2013-2020
Figure 4-27: Global – Interferon Market by Segment (%) (2014)
Figure 4-28: Global – Interferon Alpha Market (Billion US$), 2012-2014
Figure 4-29: Global – Interferon Beta Market (Billion US$), 2012-2014
Figure 4-30: US – Interferon Market (Billion US$), 2013-2020
Figure 4-31: Europe – Interferon Market (Billion US$), 2013-2020
Figure 4-32: Global – Interferon Market by Key Player (%) (2014)
Figure 4-33: Global – Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-34: US – Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-35: Europe – Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-36: Global – Human Growth Hormone Market by Key Players (%) (2014)
Figure 4-37: Global – Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-38: Global – Blood Clotting Factor Market by Segment (%) (2014)
Figure 4-39: Global – Blood Clotting Recombinant Factor VIII Market (Billion US$), 2013-2020
Figure 4-40: Global – Recombinant Blood Clotting Factor VII Market (Billion US$), 2013-2020
Figure 4-41: Global – Recombinant Blood Clotting Factor Market IX (Billion US$), 2013-2020
Figure 4-42: US – Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-43: Europe – Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-44: Global – Blood Clotting Factor Market by Key Players (%) (2014)
Figure 4-45: Global – Follicle Stimulating Hormone Market (Billion US$), 2013-2020
Figure 4-46: Global – Granulocyte Colony Stimulating Factor Market (Billion US$), 2013-2020
Figure 4-47: US – Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
Figure 4-48: Europe – Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
Figure 7-1: Porters Five Forces Analysis
List of Tables:
Table 3-1: US & Europe – Major Drugs Patent Expiry in Protein Therapeutics Market
Table 4-1: Global – Key Players and Drugs in Monoclonal Antibody Market (Billion US$), 2012-2014
Table 4-2: Global – Key Players and Drugs in Erythropoietin Alfa Market (Billion US$), 2012-2014
Table 4-3: Global – Key Players and Drugs in Erythropoietin Beta Market (Billion US$), 2012-2014
Table 4-4: Global – Key Players and Drugs in Darbepoetin Market (Billion US$), 2012-2014
Table 4-5: US – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035f
Table 4-6: Europe – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 4-7: China – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035f
Table 4-8: Global – Key Players and Drugs in Interferon Alpha Market (Billion US$), 2012-2014
Table 4-9: Global – Key Players and Drugs in Interferon Beta Market (Billion US$), 2012-2014
Table 4-10: Global – Key Players and Drugs in Human Growth Hormone Market (Billion US$), 2012-2014
Table 4-11: Global – Key Players and Drugs in Blood Clotting Factor Market (Billion US$), 2012-2014
Table 4-12: Global – Key Players and Drugs in Follicle Stimulating Hormone Market (Billion US$), 2012-2014
Table 4-13: Global – Key Players and Drugs in Granulocyte Colony Stimulating Factor Market (Billion US$), 2012-2014
Table 5-1: Advanced Phase Protein Therapeutics
Table 8-1: Johnson & Johnson – Key Products in Protein Therapeutics
Table 8-2: Biogen – Key Products in Protein Therapeutics
Table 8-3: Eli Lilly – Key Products in Protein Therapeutics
Table 8-4: Sanofi-Aventis – Key Products in Protein Therapeutics
Table 8-5: Merck Serono – Key Products in Protein Therapeutics
Table 8-6: Roche – Key Products in Protein Therapeutics
Table 8-7: Amgen Inc. – Key Products in Protein Therapeutics
Table 8-8: Pfizer Inc. – Key Products in Protein Therapeutics
Table 8-9: Abbott Laboratories – Key Products in Protein Therapeutics
Table 8-10: Novo Nordisk – Key Products in Protein Therapeutics
【レポート販売概要】
■ タイトル：世界のタンパク質治療薬市場■ 英文：Global Protein Therapeutics Market Outlook 2020
■ 発行日：2015年9月
■ 調査会社：RNCOS
■ 商品コード：RNCOS50908
■ 調査対象地域：グローバル
- Sojitz Corporation：石油・ガスバリューチェーン分析レポート2013Sojitz Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Sojitz Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Sojitz Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- 加齢黄斑変性(AMD)：世界の臨床試験レビュー（2014年上半期）Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014" provides data on the Age Related Macular Degeneration clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Age Related Macular Degeneration. It inclu …
- 感染症検査のグローバル市場：新技術、最新検査、市場予測、競争優位Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. “Infectious Disease Testing: A Rapidly Growing and Challenging Market Facing Suppliers--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease …
- 世界の通信パワーシステム市場動向（2012-2016）TechNavio's analysts forecast the Global Telecom Power System market to grow at a CAGR of 4.21 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing deployment of telecom network infrastructures. The Global Telecom Power System market has also been witnessing the increase in ultra-high capacity optical networks. However, the declining profit …
- 世界のナノコーティング市場：自動車産業用途Surface protection is a key area in the automobile market both for protection from UV, wear, heat; promotion of adhesion; and reduction of engine friction. The overall world automotive paints and coatings market was estimated to be $7.75billion in 2010 and nanomaterials will play a key role in future growth. Desirable functional properties for the automotive coatings industry afforded by nanomater …
- 植物タンパク質加水分解物の世界市場2019-2023Global Hydrolyzed Plant Protein Market: About this market Technavio’s hydrolyzed plant protein market analysis considers sales from hydrolyzed soy protein, hydrolyzed pea protein, and hydrolyzed wheat protein. Our analysis also considers the sales of hydrolyzed plant protein in APAC, Europe, North America, South America, and MEA. In 2018, the hydrolyzed soy protein segment had a significant market …
- モノクローナル抗体（mAb）バイオシミラーの世界市場2016-2020About Biosimilars Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product. Technavio’s analysts forecas …
- インスタントコーヒーの世界市場2016-2020：噴霧乾燥インスタントコーヒー、凍結乾燥インスタントコーヒーAbout Instant Coffee Instant coffee is prepared by vaporizing brewed coffee beans. It is available in the form of powder and differs from freshly brewed coffee in terms of flavor and aroma. The main advantage of instant coffee is the convenience in preparing it. Also, it requires less equipment for preparation. Although fresh coffee dominates the overall coffee market, instant coffee continues to …
- Male Hypogonadism：グローバル臨床試験レビューH1, 2013Male Hypogonadism Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H1, 2013" provides data on the Male Hypogonadism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Male Hypogonadism. It includes an overview of the trial numbers and their recruitment s …
- 電気モーター用ドライブの世界市場：ACドライブ、DCドライブAbout Electric Drives An electric drive is a device used to regulate the speed and direction of motors. This is achieved by varying the flow of current through the motor. Drives are classified into two broad categories based on the type of current: AC drives and DC drives. AC drives are used to control AC electric motors, while DC drives are used for DC electric motors. Drives are widely used to r …
- ドライアイ症候群治療薬の世界市場予測および分析（～2024）PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Assessment to 2024 Summary Dry Eye Syndrome (DES), also known as keratoconjunctivitis sicca, is a multifactorial disease of the tears and ocular surface. This ocular condition can cause ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new the …
- シンガポールのデータセンター市場About data center A data center is a centralized facility for data computing, processing, and storage purposes. It includes high-performance servers, networking equipment, storage arrays, and supporting services such as powering and cooling solutions. Data centers are established by enterprises dealing in cloud-based service offerings. There are also many enterprises that are involved in the const …
- Opioid-Induced Constipation：市場分析及び予測（～2017）OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2017 Summary The Opioid-Induced Constipation (OIC) is a new and rapidly establishing market currently dominated by OTC laxatives set to undergo substantial growth between 2012 and 2017. The main drivers of growth will be an increase in the diagnosed OIC population. This is fuelled by a relaxation of regulation …
- ヘルニア修復：グローバル市場分析と予測MediPoint: Hernia Repair - Global Analysis and Market Forecasts Summary Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation biologic and composite meshes in developed countries and adoption of laparoscopic techniques worldwide, will drive hernia repair market growth in the US, Europe and Asia Pacific. Saturate …
- 眼科治療の世界市場2019-2023About this market The new drug approvals and strong drug pipeline will trigger the ophthalmology therapeutics market growth in the forthcoming years. Top players in the market are focusing on the development of disease-modifying drugs for treating the rising incidences of eye diseases. Furthermore, several market players are focusing on achieving new drug approvals and gene therapy approvals for t …
